Ledger.Open graph →
SEC Form D · filed December 27, 2019

Promentis Pharmaceuticals, Inc

Offering
$6.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MILWAUKEE, WI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Steve Squinto · Milwaukee, WIDirectorChad Beyer · Milwaukee, WIExecThomas Beck · Cambridge, MADirectorPatrick Schwarz-Schuette · Milwaukee, WIDirectorKlaus Veitinger · New York, NYDirectorDaniel Lawton · Milwaukee, WIExec · DirectorStacey Seltzer · Milwaukee, WIDirectorChad Beyer · Milwaukee, WIExecSteve Squinto · Milwaukee, WIDirectorThomas Beck · Newark, NJDirectorPatrick Schwarz-Schuette · Milwaukee, WIDirectorKlaus Veitinger · Newark, NJDirectorDaniel Lawton · Milwaukee, WIExec · DirectorStacey Seltzer · Milwaukee, WIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗